☰

Melanie I. Herscovitch, Ph.D. - Publications

Affiliations: 
2010 Boston University, Boston, MA, United States 
Area:
Molecular Biology, Biochemistry
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Cote SM, Gilmore TD, Shaffer R, Weber U, Bollam R, Golden MS, Glover K, Herscovitch M, Ennis T, Allen KN, Whitty A. Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity. Biochemistry. 52: 9141-54. PMID 24266532 DOI: 10.1021/Bi401368R  0.617
2011 Thompson RC, Herscovitch M, Zhao I, Ford TJ, Gilmore TD. NF-κB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway Journal of Biological Chemistry. 286: 1675-1682. PMID 20947507 DOI: 10.1074/Jbc.M110.177063  0.575
2009 Chin M, Herscovitch M, Zhang N, Waxman DJ, Gilmore TD. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile. Oncogene. 28: 2100-11. PMID 19377508 DOI: 10.1038/Onc.2009.74  0.604
2008 Herscovitch M, Comb W, Ennis T, Coleman K, Yong S, Armstead B, Kalaitzidis D, Chandani S, Gilmore TD. Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. Biochemical and Biophysical Research Communications. 367: 103-8. PMID 18164680 DOI: 10.1016/J.Bbrc.2007.12.123  0.526
2006 Gilmore TD, Herscovitch M. Inhibitors of NF-κB signaling: 785 and counting Oncogene. 25: 6887-6899. PMID 17072334 DOI: 10.1038/Sj.Onc.1209982  0.574
Show low-probability matches.